ACM Research (ACMR)
(Delayed Data from NSDQ)
$17.86 USD
-0.56 (-3.04%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $17.50 -0.36 (-2.02%) 7:40 PM ET
4-Sell of 5 4
B Value C Growth B Momentum B VGM
Income Statements
Fiscal Year end for ACM Research, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 558 | 389 | 260 | 157 | 108 |
Cost Of Goods | 282 | 205 | 145 | 87 | 57 |
Gross Profit | 276 | 184 | 115 | 70 | 51 |
Selling & Adminstrative & Depr. & Amort Expenses | 180 | 125 | 76 | 48 | 33 |
Income After Depreciation & Amortization | 96 | 59 | 39 | 21 | 18 |
Non-Operating Income | 23 | 10 | 5 | -1 | 2 |
Interest Expense | 3 | 2 | 1 | 1 | 1 |
Pretax Income | 116 | 67 | 43 | 19 | 19 |
Income Taxes | 19 | 17 | 0 | -2 | -1 |
Minority Interest | 20 | 11 | 5 | 3 | 1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 97 | 51 | 43 | 22 | 19 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 77 | 39 | 38 | 19 | 19 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 104 | 64 | 41 | 23 | 19 |
Depreciation & Amortization (Cash Flow) | 8 | 5 | 2 | 1 | 1 |
Income After Depreciation & Amortization | 96 | 59 | 39 | 21 | 18 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 64.87 | 65.34 | 65.36 | 63.55 | 57.41 |
Diluted EPS Before Non-Recurring Items | 1.20 | 0.71 | 0.57 | 0.37 | 0.39 |
Diluted Net EPS (GAAP) | 1.16 | 0.59 | 0.58 | 0.30 | 0.33 |
Fiscal Year end for ACM Research, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 202.48 | 152.19 | 170.32 | 168.57 | 144.58 |
Cost Of Goods | 105.70 | 73.07 | 91.25 | 80.06 | 75.94 |
Gross Profit | 96.78 | 79.12 | 79.08 | 88.51 | 68.64 |
SG&A, R&D, and Dept/Amort Expenses | 59.19 | 53.89 | 55.71 | 55.34 | 38.21 |
Income After SG&A, R&D, and Dept/Amort Expenses | 37.59 | 25.23 | 23.37 | 33.17 | 30.43 |
Non-Operating Income | 4.07 | 2.01 | 8.75 | -0.82 | 11.45 |
Interest Expense | 0.93 | 0.78 | 0.70 | 0.64 | 0.65 |
Pretax Income | 40.74 | 26.46 | 31.43 | 31.71 | 41.24 |
Income Taxes | 9.34 | 4.37 | 8.13 | 0.72 | 7.64 |
Minority Interest | 7.19 | 4.66 | 5.60 | 5.32 | 6.77 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 31.40 | 22.09 | 23.30 | 30.99 | 33.60 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 24.21 | 17.43 | 17.70 | 25.68 | 26.83 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 67.06 | 66.24 | 65.91 | 65.45 | 64.93 |
Diluted EPS Before Non-Recurring Items | 0.33 | 0.30 | 0.23 | 0.41 | 0.45 |
Diluted Net EPS (GAAP) | 0.35 | 0.26 | 0.25 | 0.39 | 0.41 |